The cost of CAR T-cell therapy means that the highly effective cancer treatment is unavailable in many parts of the world.

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

A groundbreaking international trial, Optima, reveals a genomic test, Prosigna, can identify breast cancer patients unlikely ...

Applies to most patients with one or two positive sentinel lymph nodes ...

Omitting completion axillary lymph node dissection does not increase risk for death for patients with clinically node-negative breast cancer, but it does significantly improve arm distress.Data from ...

A CANCER jab available on the NHS can melt away tumours when patients have run out of options, a trial found. Triple-action injection amivantamab works by blocking a growth protein and an enzyme ...

Apollo Hospitals Chennai, a leader in robotic-assisted cancer care, has performed the world's first Video Endoscopic Inguinal Lymphadenectomy (VEIL) using the Hugo Robotic-Assisted Surgery (RAS) ...

As many as 5,000 women a year with hormone-sensitive breast cancer could benefit ...

The former attorney general announced that she was diagnosed with cancer shortly after her departure from the DOJ in April.

Women with breast cancer could be spared chemotherapy thanks to a new genetic test. A breakthrough trial has found that women ...

While we tend to quickly forget having been ill or having received a vaccine, the immune system remembers remarkably well. It ...

Scientists developed a DNA or gene test that can differentiate between patients who are likely to benefit from the treatment and those who are not, a clinical trial has shown.